US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US5955108A
(en)
*
|
1994-12-16 |
1999-09-21 |
Quadrant Healthcare (Uk) Limited |
Cross-linked microparticles and their use as therapeutic vehicles
|
GB9606188D0
(en)
*
|
1996-03-23 |
1996-05-29 |
Danbiosyst Uk |
Pollysaccharide microspheres for the pulmonary delivery of drugs
|
GB9606677D0
(en)
*
|
1996-03-29 |
1996-06-05 |
Glaxo Wellcome Inc |
Process and device
|
GB9607035D0
(en)
*
|
1996-04-03 |
1996-06-05 |
Andaris Ltd |
Spray-dried microparticles as therapeutic vehicles
|
GB9610341D0
(en)
*
|
1996-05-17 |
1996-07-24 |
Andaris Ltd |
Formulation for inhalation
|
WO1997044015A1
(en)
*
|
1996-05-17 |
1997-11-27 |
Andaris Limited |
Microparticles and their use in wound therapy
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
USRE37053E1
(en)
|
1996-05-24 |
2001-02-13 |
Massachusetts Institute Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5855913A
(en)
*
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
GB9615435D0
(en)
*
|
1996-07-23 |
1996-09-04 |
Andaris Ltd |
Spray-dried product and its therapeutic use
|
WO1998017318A1
(en)
*
|
1996-10-19 |
1998-04-30 |
Quadrant Healthcare (Uk) Limited |
Use of hollow microcapsules in diagnosis and therapy
|
GB9621825D0
(en)
*
|
1996-10-19 |
1996-12-11 |
Andaris Ltd |
Microparticles and their use as therapeutic vehicles
|
AU5719798A
(en)
*
|
1996-12-31 |
1998-07-31 |
Inhale Therapeutic Systems, Inc. |
Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
|
EP1498115A1
(en)
*
|
1997-01-16 |
2005-01-19 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
PT954282E
(pt)
*
|
1997-01-16 |
2005-06-30 |
Massachusetts Inst Technology |
Preparacao de particulas para inalacao
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
ATE239447T1
(de)
*
|
1997-09-29 |
2003-05-15 |
Inhale Therapeutic Syst |
In verneblern verwendbare, stabilisierte zubereitungen
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
GB9727102D0
(en)
*
|
1997-12-22 |
1998-02-25 |
Andaris Ltd |
Microparticles and their therapeutic use
|
EP1056484A1
(en)
*
|
1998-02-20 |
2000-12-06 |
Quadrant Healthcare (UK) Limited |
Products comprising fibrinogen for use in therapy
|
EP1273290A1
(en)
*
|
1998-06-24 |
2003-01-08 |
Advanced Inhalation Research, Inc. |
Large porous particles emitted from an inhaler
|
ES2198922T3
(es)
*
|
1998-06-24 |
2004-02-01 |
Advanced Inhalation Research, Inc. |
Particulas porosas grandes emitadas por un inhalador.
|
AU772798B2
(en)
*
|
1999-04-21 |
2004-05-06 |
1355540 Ontario Inc. |
Formulations for detecting asthma
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
MXPA02006079A
(es)
|
1999-12-20 |
2004-08-23 |
Nicholas J Kerkhof |
Proceso para producir particulas de nanometro mediante secado por aspersion de lecho fluido.
|
US8771740B2
(en)
*
|
1999-12-20 |
2014-07-08 |
Nicholas J. Kerkhof |
Process for producing nanoparticles by spray drying
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
AU2001264789A1
(en)
*
|
2000-06-08 |
2001-12-17 |
Eli Lilly And Company |
Protein powder for pulmonary delivery
|
ATE355849T1
(de)
*
|
2000-12-21 |
2007-03-15 |
Nektar Therapeutics |
Lagerstabile pulverzusammensetzungen mit interleukin-4 rezeptor
|
GB0111420D0
(en)
*
|
2001-05-10 |
2001-07-04 |
Biovector Solutions Ltd |
Soluble polymer systems for drug delivery
|
WO2003037303A1
(en)
|
2001-11-01 |
2003-05-08 |
Nektar Therapeutics |
Spray drying methods and compositions thereof
|
ATE508735T1
(de)
|
2001-12-19 |
2011-05-15 |
Novartis Ag |
Pulmonale verabreichung von aminoglykosiden
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
EP1589901A4
(en)
|
2002-12-20 |
2006-08-09 |
Generipharm Inc |
INTRACUTANEOUS INJECTION
|
AU2004251623B2
(en)
|
2003-05-28 |
2010-03-18 |
Novartis Ag |
Spray drying of an alcoholic aqueous solution for the manufacture of a water-in-soluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
|
EP1646445A4
(en)
|
2003-07-18 |
2007-09-19 |
Baxter Int |
METHOD OF MANUFACTURING, USING AND COMPOSING SMALL BALLULAR PARTICLES PRODUCED BY CONTROLLED PHASE SEPARATION
|
DE10339197A1
(de)
*
|
2003-08-22 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US8333995B2
(en)
|
2004-05-12 |
2012-12-18 |
Baxter International, Inc. |
Protein microspheres having injectable properties at high concentrations
|
JP2010505883A
(ja)
|
2006-10-12 |
2010-02-25 |
ザ ユニバーシティー オブ クイーンズランド |
免疫応答を調節するための組成物および方法
|
EP2050437A1
(en)
*
|
2007-10-15 |
2009-04-22 |
Laboratoires SMB |
Improved pharmaceutical dry powder compositions for inhalation.
|
UA90013C2
(ru)
*
|
2008-03-19 |
2010-03-25 |
Давид Анатолійович Нога |
Фармацевтическая композиция, содержащая инсулин, и способ его получения
|
US11524058B2
(en)
|
2008-09-29 |
2022-12-13 |
The Corporation Of Mercer University |
Oral dissolving films containing microencapsulated vaccines and methods of making same
|
US10463608B2
(en)
|
2008-09-29 |
2019-11-05 |
The Corporation Of Mercer University |
Microneedle-based transdermal delivery system and method of making same
|
CA2738855A1
(en)
|
2008-09-29 |
2010-04-01 |
The Corporation Of Mercer University |
Nanospheres encapsulating bioactive material and method for formulation of nanospheres
|
US10004790B2
(en)
|
2008-09-29 |
2018-06-26 |
The Corporation Of Mercer University |
Nanospheres encapsulating bioactive material and method for formulation of nanospheres
|
US9827205B2
(en)
|
2008-12-12 |
2017-11-28 |
Mallinckrodt Pharma Ip Trading D.A.C. |
Dry powder fibrin sealant
|
EP2216054A1
(en)
|
2009-02-06 |
2010-08-11 |
ProFibrix BV |
Biodegradable extravascular support
|
ES2593584T3
(es)
*
|
2009-05-28 |
2016-12-09 |
Profibrix Bv |
Sellante de fibrina en polvo seco
|
GB0909136D0
(en)
|
2009-05-28 |
2009-07-01 |
Profibrix Bv |
Dry powder composition
|
GB0909131D0
(en)
|
2009-05-28 |
2009-07-01 |
Quadrant Drug Delivery Ltd |
Dry powder fibrin sealant
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
KR20120125465A
(ko)
|
2010-01-08 |
2012-11-15 |
프로피브릭스 비.브이. |
건조 분말 피브린 실란트
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
AU2011325857A1
(en)
|
2010-11-01 |
2013-05-02 |
University Of Technology, Sydney |
Immune-modulating agents and uses therefor
|
EP3225235B1
(en)
|
2011-03-10 |
2020-12-16 |
Xeris Pharmaceuticals, Inc. |
Stable peptide formulations for parenteral injection
|
CN105853348B
(zh)
|
2011-03-10 |
2019-08-30 |
Xeris药物公司 |
肠胃外注射用稳定溶液
|
RU2013155713A
(ru)
|
2011-07-06 |
2015-08-20 |
Профибрикс Бв |
Составы для лечения ран
|
KR102007057B1
(ko)
|
2011-10-31 |
2019-08-02 |
엑스에리스 파머수티클스, 인크. |
당뇨병 치료를 위한 제형물
|
EP2836204B1
(en)
|
2012-04-13 |
2020-07-08 |
GlaxoSmithKline Intellectual Property Development Limited |
Aggregate particles
|
US10350314B2
(en)
*
|
2012-06-26 |
2019-07-16 |
Ge Healthcare As |
Preparation of composition comprising gas microbubbles
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
US9597339B2
(en)
|
2013-02-01 |
2017-03-21 |
Glialogix, Inc. |
Compositions and methods for the treatment of neurodegenerative and other diseases
|
WO2014124096A1
(en)
|
2013-02-06 |
2014-08-14 |
Perosphere Inc. |
Stable glucagon formulations
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
WO2015054280A1
(en)
|
2013-10-08 |
2015-04-16 |
Lam Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
EP4218742A1
(en)
|
2014-04-04 |
2023-08-02 |
AI Therapeutics, Inc. |
An inhalable rapamycin formulation for treating age-related conditions
|
WO2015179918A1
(en)
|
2014-05-27 |
2015-12-03 |
The University Of Queensland |
Modulation of cellular stress
|
EP3185932A1
(en)
|
2014-08-06 |
2017-07-05 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
KR20170095807A
(ko)
|
2014-10-07 |
2017-08-23 |
램 테라퓨틱스, 인코포레이티드 |
폐 고혈압의 치료를 위한 흡입가능 라파마이신 제제
|
WO2016196976A1
(en)
|
2015-06-04 |
2016-12-08 |
Xeris Pharmaceuticals, Inc. |
Glucagon delivery apparatuses and related methods
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
EP3307295A1
(en)
|
2015-06-10 |
2018-04-18 |
Xeris Pharmaceuticals, Inc. |
Use of low dose glucagon
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
WO2017062463A1
(en)
|
2015-10-05 |
2017-04-13 |
The Corporation Of Mercer University |
Nanospheres encapsulating bioactive material and method for formulation of nanospheres
|
US11628208B2
(en)
|
2015-10-05 |
2023-04-18 |
The Corporation Of Mercer University |
System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
|
TW201818933A
(zh)
|
2016-10-21 |
2018-06-01 |
美商吉利亞洛吉克斯公司 |
用於神經退化性及其他疾病的治療之組成物和方法
|
JP7299166B2
(ja)
|
2017-06-02 |
2023-06-27 |
ゼリス ファーマシューティカルズ インコーポレイテッド |
沈殿抵抗性低分子薬物製剤
|
WO2021090214A2
(en)
*
|
2019-11-04 |
2021-05-14 |
Alesco S.R.L. |
Sucrosomial® berberine, its compositions and their use
|